secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOGEN INC. (BIIB)
CIK:        0000875045
Form:       8-K/A
Filed at:   2026-06-10T20:49:37+00:00
Accession:  0000950157-26-000699
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biogen amends 8-K to note Apellis acquisition not significant, no financial statements required
--------------------------------------------------------------------------------

- Acquisition of Apellis closed May 14, 2026; deemed not significant under Regulation S-X after further analysis.
- Items 9.01(a) and (b) financial statements and pro forma information not required; prior obligation withdrawn.
- All other disclosures from the Original Report regarding the merger remain unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875045/000095015726000699/0000950157-26-000699-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875045/000095015726000699/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0000950157-26-000699

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer